Related Experiment Videos
TAVR and SAVR in ESRD: Just because we can doesn't necessarily mean that we should
1Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Canada.
Abstract:
In patients with end stage renal disease on hemodialysis, TAVR resulted in reduced length of stay, hospitalization cost, complication rate and higher rates of home discharge compared to SAVR. In-hospital mortality and complication rates were high in both groups. Careful patient selection and further research is required to identify patients with end-stage renal disease who might, or might not, benefit from intervention.